How is allergy immunotherapy administered?

There are several formulations and treatment can be administered either via subcutaneous injections (SCIT) or via sublingual (SLIT) drops or tablets. For both methods, the principle is the same: the patient receives repeated amounts of the triggering allergen over time. This can be performed with an initiation phase (dose increasing) followed by a maintenance phase.

Subcutaneous immunotherapy (also known as “allergy shots” or SCIT): the allergen is administered by subcutaneous injections under the skin of the arm. These ‘shots’ are given at a doctor’s office so that the doctor can monitor how the patient reacts to the therapy. The doses are administered on a scheduled weekly or monthly basis, depending on the course of the AIT treatment

Sublingual immunotherapy (also known as SLIT): the allergen is administered in the form of drops or tablets that are placed under the tongue, generally every day. It is generally recommended to take the first treatment in the physician’s office to assess how the patient react to treatment, subsequent doses are self-administered at home

SCIT and SLIT treatments are flexible in terms of frequency of dosing and number of allergen doses delivered to meet individual patient needs and profile.

Learn more about Stallergenes Greer's appoach to AIT


Cookies Management